MAPK2 Blocking Peptide

General Information

Product

MAPK2 Peptide

Description

Antigenic Blocking Peptide Mitogen-activated protein kinase 2 Antibody

Verified Applications

Immunodepletion, Immunocompetition

Peptide Description

Synthetic peptide taken within amino acid region 300-350 on human Mitogen-activated protein kinase 2.

Accession #

NCBI:  NP_116584

Physical Properties

Quantity

250 µg

Volume

100 µl

Form

Antigenic Blocking Peptide

Storage

-20⁰C for long term storage

Application Protocol

Competition/Depletion assay

Refer to competition assay protocol

Protein

Uniprot #

P49137

Overview

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, ELAVL1, HNRNPA0, HSF1, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36.

Molecular Function

Kinase, Serine/threonine-protein kinase, Transferase

Subcellular Location

Cytoplasm, Nucleus

Expression

Expressed in all tissues examined.

Structure

Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family.

Contains 1 protein kinase domain.

Alternative Nomenclature

ERK 2 antibody

ERT1 antibody
Extracellular Signal Regulated Kinase 2 antibody

MAP kinase 2 antibody

MAPK 2 antibody
Mitogen-activated protein kinase 2 antibody
protein kinase, mitogen-activated, 2 antibody
protein tyrosine kinase ERK2 antibody